Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats

Carcinogenesis

Volumn 25, Issue 10, 2004, Pages 1967-1972

  Kawamori, Toshihiko ^a   Totsuka, Yukari ^b   Uchiya, Naoaki ^b   Kitamira, Tomohiro ^b   Shibata, Hideyuki ^b   Sugimura, Takashi ^b   Wakabayashi, Keiji ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHENYLNORHARMAN; ANILINE; APC PROTEIN; BETA CARBOLINE; BETA CATENIN; CHEMICAL MUTAGEN; CYTOPLASM PROTEIN; CYTOSINE; GENOMIC DNA; GUANINE; K RAS PROTEIN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASE PAIRING; CANCER INCIDENCE; CELL NUCLEUS; CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; CHEMICAL STRUCTURE; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; LEUKEMOGENESIS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MONONUCLEAR CELL; MUTAGEN TESTING; NONHUMAN; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; RAT STRAIN; SINGLE STRAND CONFORMATION POLYMORPHISM; STRUCTURE ANALYSIS; THYROID CARCINOMA;

ADENOCARCINOMA; ANILINE COMPOUNDS; ANIMALS; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; COLON; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; FEMALE; GENES, APC; GENES, RAS; HARMINE; INDOLES; LEUKEMIA; LIVER; LIVER NEOPLASMS; MALE; MUTAGENS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PYRIDINES; RATS; RATS, INBRED F344; THYROID NEOPLASMS; TRANS-ACTIVATORS;

EID: 6444224314     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh189     Document Type: Article

References (33)

1. Sugimura,T., Kawachi,T., Nagao,M. et al. (1977) Mutagenic principle(s) in tryptophan and phenylalanine pyrolysis products, Proc. Jpn. Acad., 53, 58-61.
2. Sugimura,T., Nagao,M. and Wakabayashi,K. (1982) Metabolic aspects of the comutagenic action of norharman. In Snyder,R., Jollow,D.J., Parke,D.V., Gibson,C.G., Kocsis,J.J. and Witmer,C.M. (eds), Biological Reactive Intermediates-II, Chemical Mechanisms and Biological Effects Part B. Plenum Press, New York and London, pp. 1011-1025.
3. Totsuka,Y., Ushiyama,H., Ishihara,J., Sinha,R., Goto,S., Sugimura,T. and Wakabayashi,K. (1999) Quantification of the co-mutagenic β-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods. Cancer Lett., 143, 139-143.
4. Ushiyama,H., Oguri,A., Totsuka,Y., Itoh,H., Sugimura,T. and Wakabayashi,K. (1995) Norharman and harman in human urine. Proc. Jpn. Acad., 71B, 57-60.
5. Nagao,M., Yahagi,T., Honda,M., Seino,Y., Matsushima,T. and Sugimura,T. (1977) Demonstration of mutagenicity of aniline and o toluidine by norharman. Proc. Japan Acad., 53B, 34-37.
6. Luceri,F., Giuseppe,P., Moneti,G. and Dolara,P. (1993) Primary aromatic amines from side-stream cigarette smoke are common contaminants of indoor air. Toxicol. Ind. Health, 9, 405-413.
7. International Agency for Research on Cancer (IARC) (1982). Aniline and aniline hydrochloride. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC, IARC Scientific Publication, Lyon, 27, 39-61.
8. Riffelmann,M., Muller,G., Schmieding,W., Popp,W. and Norpoth,K. (1995) Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons. Int. Arch. Occup. Environ. Health, 68, 36-43.
9. DeBruin,L.S., Pawliszyn,J.B. and Josephy,P.D. (1999) Detection of monocyclic aromatic amines, possible mammary carcinogenesis, in human milk. Chem. Res. Toxicol., 12, 78-82.
10. Bayoumy,K.E., Donahue,J.M., Hecht,S.S. and Hoffmann,D. (1986) Identification and quantitative determination of aniline and toluidines in human urine. Cancer Res., 46, 6064-6067.
11. Totsuka,Y., Hada,N., Matsumoto,K., Kawahara,N., Murakami,Y., Yokoyama,Y., Sugimura,J. and Wakabayashi,K. (1998) Structural determination of a mutagenic aminophenylnorharman produced by the co-mutagen norharman with aniline. Carcinogenesis, 19, 1995-2000.
12. Sugimura,T. (1998) A new concept of co-mutagenicity from a phenomenon forgotten for the past two decades: is it more important than previously expected? Environ. Health Perspect., 106, A522-A523.
13. Totsuka,Y., Takamura-enya,T., Nishigaki,R., Sugimura,T. and Wakabayashi,K. (2004) Mutagens formed from β-carboline with aromatic amines. J. Chromatogr. B, 802, 135-141.
14. Totsuka,Y., Takamura-Enya,T., Kawahara,N., Nishigaki,R., Sugimura,T. and Wakabayashi,K. (2002) Structure of DNA adduct formed with aminophenylnorharman, being responsible for the comutagenic action of norharman with aniline. Chem. Res. Toxicol., 15, 1288-1294.
15. Ohe,T., Takata,T., Maeda,Y., Totsuka,Y., Hada,N., Matsuoka,A., Tanaka,N. and Wakabayashi,K. (2002) Induction of sister chromatid exchanges and chromosome aberrations in cultured mammalian cells treated with aminophenylnorharman formed by norharman with aniline. Mutat. Res. 515, 181-188.
16. Totsuka,Y., Kataoka,H., Takamura-Enya,T., Sugimura,T. and Wakabayashi,K. (2002) In vitro and in vivo formation of aminophenyl-norharman from norharman and aniline. Mutat. Res., 506-507, 49-54.
17. Kawamori,T., Totsuka,Y., Ishihara,J., Uchiya,N., Sugimura,T. and Wakabayashi,K. (2001) Induction of liver preneoplastic lesions by aminophenylnorharman, formed from norharman and aniline, in male F344 rats. Cancer Lett., 163, 157-161.
18. Boorman,G. A., Eustis,S. L., Elwell,M. R., Montgomery,J. C.A. and MacKenzie,W. F. (eds) (1990) Pathology of the Fischer Rat. Academic Press, Inc., San Diego, pp. 1-553.
19. Kudo,M., Ogura,T., Esumi,H. and Sugimura,T. (1991) Mutational activation of c-Ha-ras gene in squamous cell carcinomas of rat Zymbal gland induced by carcinogenic heterocyclic amines. Mol. Carcinogen. 4, 36-47.
20. Takahashi,M., Minamoto,T., Sugimura,T. and Esumi,H. (1993) High frequency and low specificity of ras gene mutations in rat Zymbal's gland tumors induced by 2-amino-3-methylimidazo[4,5-fquinoline. Carcinogenesis, 14, 1355-1357.
21. Takahashi,M., Fukuda,K., Sugimura,T. and Wakabayashi,K. (1998) Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res., 58, 42-46.
22. Hirayama,Y., Wakazono,K., Yamamoto,M., Kitano,M., Tatematsu,M., Nagao,M., Sugimura,T. and Ushijima,T. (1999) Rare mutations of p53, Ki-ras and beta-catenin genes and absence of K-sam and c-erbB-2 amplification in N-methyl-N'-nitro-N-nitrosoguanidine-induced rat stomach cancers. Mol. Carcinogenesis, 25, 42-47.
23. Kakiuchi,H., Watanabe,M., Ushijima,T., Toyota,M., Imai,K., Weisburger,J. H., Sugimura,T. and Nagao,M. (1995) Specific 5′-GGGA-3′- > 5′-GGA-3′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc. Natl Acad. Sci. USA, 92, 910-914.
24. Ubagai,T., Ochiai,M., Kawamori,T., Imai,H., Sugimura,T., Nagao,M. and Nakagama,H. (2002) Efficient induction of rat large intestinal tumors with a new spectrum of mutations by intermittent administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in combination with a high fat diet. Carcinogenesis, 23, 197-200.
25. Yamashita,Y., Yoshimi,N., Sugie,S., Suzui,S., Matsunaga,K., Kawabata,K., Hara,A. and Mori,H. (1999) β-Catenin (Ctnnb1) gene mutations in diethylnitrosamine (DEN)-induced liver tumors in male F344 rats. Jpn. J. Cancer Res., 90, 824-828.
26. Tsujiuchi,T., Tsutsumi,M., Sasaki,Y., Takahama,M. and Konishi,Y. (1999) Different frequencies and patterns of β-catenin mutations in hepatocellular carcinomas induced by N nitrosodiethylamine and a choline-deficient 1-amino acid-deficient diet in rats. Cancer Res., 59, 3904-3907.
27. Kondo,Y., Kanai,Y., Sakamoto,M., Genda,T., Mizokami,M., Ueda,R. and Hirohashi,S. (1999) Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma. Jpn. J. Cancer Res., 90, 1301-1309.
28. Dashwood,R.H., Suzui,M., Nakagama,H., Sugimura,T. and Nagao,M. (1998) High frequency of β-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res., 58, 1127-1129.
29. Konishi,M., Kikuchi-Yanoshita,R., Tanaka,K. et al. (1996) Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis and sporadic colon cancer. Gastroenterology 111, 307-317.
30. Masumura,K., Totsuka,Y., Wakabayashi,K. and Nohmi,T. (2003) Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse. Carcinogenesis, 24, 1985-1993.
31. Kato,T., Ohgaki,H., Hasegawa,H., Sato,S., Takayama,S. and Sugimura,T. (1988) Carcinogenicity in rats of a mutagenic compound, 2-amino-3, 8-dimethylimidazo[4,5-fquinoxaline. Carcinogenesis 9, 71-73.
32. Nagao,M., Yahagi,T. and Sugimura,T. (1978) Differences in effects of norharman with various classes of chemical mutagens and amounts of S-9. Biochem. Biophys. Res. Commun., 83, 373-378.
33. Hada,N., Totsuka,Y., Enya,T., Tsurumaki,K., Nakazawa,M., Kawahara,N., Murakami,Y., Yokoyama,Y., Sugimura,T. and Wakabayashi,K. (2001) Structures of mutagens produced by the co-mutagen norharman with o- and m-toluidine isomers. Mutat. Res., 493, 115-126.